Annals of Nutrition and Metabolism · 2011 · 58 citations · 18 references
MedicineEndocrinologyPharmacologyClinical PharmacologyDiabetologyHuman NutritionDiabetes ControlDiabetes MellitusDiabetes PharmacotherapyGlycemic ControlInsulin ResistancePlacebo EffectImpaired Insulin SensitivityInsulin ActionInsulin Resistance AssessmentInsulin Sensitivity IndicesOral Hypoglycemic ManagementOral Hypoglycemic TherapyType 2 Diabetes PharmacotherapyType 2 Diabetes Treatment
BACKGROUND: Pinitol is thought to mediate insulin action and improve insulin resistance. We evaluated the effects of pinitol on glycemic control, insulin resistance and adipocytokine levels in type 2 diabetic patients. MATERIAL AND METHOD: A total of 66 patients with type 2 diabetes who had been taking oral hypoglycemic agents for at least 3 months were enrolled and randomized to receive pinitol (n = 33) or matching placebo (n = 33). All subjects took 1,200 mg pinitol or placebo and maintained their current oral hypoglycemic agents throughout the study. RESULTS: Mean HbA1c, fasting plasma glucose, and HOMA-IR were significantly lowered more in patients taking pinitol than in those given a placebo. Patients who had an HbA1c over 8.0% showed a greater reduction (p < 0.01) than those who had an HbA1c below 8.0% (p =0.16). In addition, in the group of patients with a HOMA-IR over 2.5, there was a significant decrease in HbA1c compared to that in the group of patients with a HOMA-IR below 2.5. There were no differences in the changes in adiponectin, FFA and CRP between the two groups. CONCLUSIONS: Pinitol can mediate insulin action to improve glycemic control and insulin sensitivity in patients with type 2 diabetes mellitus, especially in patients with insulin resistance.
18
Kai I. Cheang, Jean‐Patrice Baillargeon, Paulina A. Essah et al. · Metabolism · 2008 · 129 citations
Effect of pinitol treatment on insulin action in subjects with insulin resistance.
Ajuah Davis, M. Christiansen, Jeffrey F. Horowitz et al. · Diabetes Care · 2000 · 107 citations · Full text